Dr. Kevin Michael Reavis, MD

Dr. Reavis practices at Providence Portland Medical Center in Portland, Oregon, part of Providence Health & Services.

Dr. Reavis' NPI, 1891749149, was assigned on May 20, 2006. Dr. Reavis graduated from Vanderbilt University School of Medicine in 1999. Dr. Reavis holds Oregon license MD24248.

Dr. Reavis' primary practice is Providence Portland Medical Center, at 4805 NE Glisan Street, Portland, OR 97213 in Multnomah County. The practice phone is (503) 215-1111.

Dr. Reavis' primary practice is Providence Portland Medical Center in Portland, Oregon, part of Providence Health & Services. Dr. Reavis is also affiliated with Providence St. Vincent Medical Center. The medical group on file is The Oregon Clinic. Dmand AI also links Dr. Reavis to 3 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reavis practices, 5 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Reavis' primary specialty in the NPI Registry, under taxonomy code 208600000X. Dmand AI has Dr. Reavis' licenses on file in 2 states: Oregon and Ohio.

CMS data shows 225 Medicare services from Dr. Reavis across 8 procedure codes in 2024, for 142 Medicare patients. Medicare paid $32,258 for them.

CMS counts 142 Medicare patients who saw Dr. Reavis in 2024. The largest group is 65 to 74, with 72 patients. 73% of them have high blood pressure, and 70% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Reavis' median patient age at 69, with 71% women.

In 2024, Dr. Reavis wrote 175 Medicare Part D claims for 61 patients. 99% of them were for generic drugs. CMS names the drug for 123 of them, across 5 drugs with 11 or more claims each, at $1,846 in total drug cost. In 2023, CMS named 101 claims across 5 drugs.

Dr. Reavis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Reavis as offering telehealth. CMS counts 171 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Reavis, more than 87% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 66 papers to Dr. Reavis, published from 2008 to 2024. 2015 was the busiest year, with 7. The most frequent topics are Laparoscopy, Gastroesophageal Reflux and Fundoplication. Dr. Reavis has published most often in Surg Endosc. Dr. Reavis' most frequent co-authors are Steven Ryan Demeester, MD, Ninh T. Nguyen, MD and Ahmed Sharata, MD.

Dmand AI links Dr. Reavis to 1 clinical trial. Conditions studied include Gastroesophageal Reflux and Esophageal Motility Disorders.

CMS Open Payments shows 114 general payments to Dr. Reavis from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 68% of the total. Boston Scientific Corporation paid the most, $23,998.

Dr. Reavis graduated from Vanderbilt University School of Medicine in 1999.